Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Examining Dietary Influences Of Liver Disease
Diets high in protein and cholesterol are associated with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk. These findings are in the July issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
generic viagra online
What Is Pulmonary Embolism? What Causes Pulmonary Embolism?
An embolism - from the Greek çİmbolos meaning "stopper" or "plug" - is the term that describes a condition where an object called an embolus is created in one part of the body, circulates throughout the body, and then blocks blood flowing through a vessel in another part of the body. Emboli (plural of embolus) are not to be confused with thrombi (plural of thrombus), which are clots that are formed and remain in one area of the body without being carried throughout the bloodstream.
plastic surgery before after
News of the day
Yale Researchers Suggests Gene Inhibition May Help Normalize Type 2 Diabetes
In research that could lead to new approaches for the treatment of type 2 diabetes, a Yale School of Medicine team has found that suppressing a liver enzyme that induces glucose production helped diminish the symptoms of the disease in a rat model - reducing blood glucose concentrations, decreasing rates of glucose production in the liver, and improving insulin sensitivity. Decreasing expression of the gene, Sirtuin 1, also lowered total cholesterol levels.
Nutrition

Cambridge Consultants To Showcase Inhaler Design And Development Process At RDD 2009, Europe

Cambridge Consultants will be showcasing its proprietary design and development process for Dry Power Inhalers (DPIs) at the Respiratory Drug Delivery (RDD) Europe 2009 conference in Lisbon later this month.÷  The company will demonstrate its ability to move inhaler design quickly through all stages of development from concept through manufacture to final product, getting it right first time, accelerating the creation of new inhalable drug delivery devices, and offering pharmaceutical companies a quick route to market, saving up to six months in development. "Our RDD presence is all about the importance of speed to market, and this demonstration is designed to highlight the range of development capabilities we can deploy to achieve it for our clients," commented David Blakey, Head of Drug Delivery at Cambridge Consultants.÷  "It is crucial to ensure process quality in stages such as concept creation, complex mathematical modelling and detailed design.÷  These are areas where Cambridge Consultants adds significant value, based on our skill and experience in running turn key developments, from concept to clinical trial and through transfer to manufacture." Cambridge Consultants will be using Gen-X, a proprietary DPI, to demonstrate the key stages in the design cycle.÷  The display tracks the stages of the process up to the test bed stage, where the efficacy of the de-aggregation engine has been tested.÷  Cambridge Consultants is currently selecting development partners to take this concept to market. David Blakey adds: "Supported by our proprietary design and development process, our partners can cut up to six months off the development cycle for DPIs, giving them a significant head start and reducing development risk." The demonstration of Cambridge Consultants" product development process will be available on Cambridge Consultants" stand at the Respiratory Drug Delivery Europe 2009 conference in Lisbon, Portugal, from 19-22 May. Cambridge Consultants


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

İ Copyright 2009